eISSN: 2300-6722
ISSN: 1899-1874
Medical Studies/Studia Medyczne
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
4/2017
vol. 33
 
Share:
Send email
Share:
abstract:
Original paper

Evaluation of the therapeutic efficacy of clindamycin in patients hospitalised with erysipelas

José Maria Pereira de Godoy
1
,
André Luís Cozetto de Oliveira
2
,
Maria de Fátima Guerreiro Godoy
2

1.
Department of the Medicine, School in São José do Rio Preto (FAMERP) and CNPq (National Council for Research and Development), Brazil
2.
Medicine School, São Jose do Rio Preto (FAMERP), Brazil
Medical Studies/Studia Medyczne 2017; 33 (4): 259–261
DOI: https://doi.org/10.5114/ms.2017.72478
Online publish date: 2017/12/31
View full text Get citation
 
PlumX metrics:
Introduction: Erysipelas is an acute skin infection of a streptococcal-related aetiology. Penicillin is the first-line antibiotic in the treatment of erysipelas; however, a number of other antibiotics are used.

Aim of the research: To evaluate the clinical response of erysipelas to clindamycin in hospitalised patients.

Material and methods: A retrospective cohort study was performed of all patients hospitalised with erysipelas and treated with the antibiotic clindamycin in Hospital de Base, São José do Rio Preto between 2000 and 2008.

Results: The efficacy of this medication was evaluated. Failure of clinical treatment was detected in 4% of the 50 patients treated with clindamycin, but no failure was seen in 51 patients who were treated with clindamycin combined with other antibiotics.

Conclusions: Clindamycin is clinically efficacious (96%) to treat patients hospitalised for erysipelas. Clindamycin is a good therapeutic option.
keywords:

erysipelas, antibiotic therapy, clindamycin, microbial resistance
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.